Tag: Formycon
Diagnostics group is probably talking to Bio-Rad about merger
Qiagen in Hilden Is the merger with Bio-Rad coming? No comment was received from either Qiagen or Bio-Rad. (Photo: Reuters) new York According to a media report, the two diagnostics…
Diagnostics group is probably talking to Bio-Rad about merger
Qiagen in Hilden Is the merger with Bio-Rad coming? No comment was received from either Qiagen or Bio-Rad. (Photo: Reuters) new York According to a media report, the two diagnostics…
Diagnostics group is probably talking to Bio-Rad about merger
Qiagen in Hilden Is the merger with Bio-Rad coming? No comment was received from either Qiagen or Bio-Rad. (Photo: Reuters) new York According to a media report, the two diagnostics…
Diagnostics group is probably talking to Bio-Rad about merger
Qiagen in Hilden Is the merger with Bio-Rad coming? No comment was received from either Qiagen or Bio-Rad. (Photo: Reuters) new York According to a media report, the two diagnostics…
Diagnostics group is probably talking to Bio-Rad about merger
Qiagen in Hilden Is the merger with Bio-Rad coming? No comment was received from either Qiagen or Bio-Rad. (Photo: Reuters) new York According to a media report, the two diagnostics…
Biosimilar biotech company achieves first approval success
Frankfurt It is not every day that German biotech companies receive product approvals for their new drug developments. The Munich Formycon has now achieved such a success both in the…
So it is with the new Alzheimer’s therapy
Neurologist Alois Alzheimer, drug Aduhelm To date, there is no drug that can cure the disease. (Photo: Mauritius Images, Getty Images, REUTERS (M)) Frankfurt “Will there be a breakthrough in…
Formycon wants to become a player in the biosimilar business
In the laboratory After Lucentis, Formycon also wants to launch biosimilars for Stelara and the eye drug Eylea by the middle of the decade. Frankfurt It is not only the…